Ted Driscoll, Board of Directors

Ted Driscoll, PhD


Ted Driscoll is a Director leading the Digital Healthcare team at Claremont Creek Ventures. He is also an active angel investor with Health Tech Capital and a founding director of the Sand Hill Angels.

Prior to his venture capital experience, Ted helped found five successful companies in imaging-related markets. He was founder and CEO of Be Here Technologies, a pioneer in Internet, Broadcast and Videoconferencing technologies. He served as a Division President and CTO of Diasonics, with responsibility for its MRI, ultrasound, digital X-ray, lithotripsy and acoustic ablation technology areas. He had earlier directed the Diasonics technology team that developed the first commercial MRI scanners and numerous advances in MR imaging. Previously, Ted was also Vice President of Engineering and R&D of Identix, now a world leader in fingerprint and face recognition; and Director of R&D at International Imaging Systems, an early pioneer in remote sensing. His research and patents in ultrasound therapy and acoustic hemostasis also led to the founding of another company, Therus, now partnered with Boston Scientific.

Ted holds a PhD from Stanford University in Digital Imaging, Masters degrees from Harvard University in Computer Graphics and Remote Sensing and a Bachelor’s degree from the University of Pennsylvania. Ted holds 40+ granted US and foreign patents in image-related fields, with approximately 30 additional pending applications.

Harsh Patel, Board of Directors

Harsh Patel, B.S., MBA


Harsh Patel brings 20 years of experience to Claremont Creek Ventures in building, operating and investing in technology growth companies.  Harsh is particularly focused on big data analytics and SaaS solutions applied to large markets in healthcare, energy, government and retail.

Harsh built a successful investing track record as a General Partner at RRE Ventures and In-Q-Tel, leading a number of early stage investments including Palantir Technologies, Tendril and Flipswap (now ERecyclingCorps). He has also been an active angel investor and mentor for a number of seed stage companies including Badgeville and SnappyTV. As an operator, Harsh was most recently President of Bina Technologies, a pioneer in big data analytics for genomics—a key enabler for personalized medicine. Earlier, Harsh was a Co-Founder of Orbit Commerce (acquired by Digital River, NASDAQ:DRIV) where he designed one of the first SaaS platforms for small business e-commerce. Harsh began his career in enterprise technology R&D for Accenture, building solutions for AstraZeneca, Johnson & Johnson and American Express.

Harsh is a founding board member of Anjna Patient Education and the University of Illinois Silicon Valley Roundtable, and a mentor to minority entrepreneurs through the NewME Accelerator. He holds an MBA from the Stanford Graduate School of Business and a B.S. in Engineering.

Gini, Board of Directors

Gini Deshpande, Ph.D.


Gini has over ten years of experience incubating, developing, and commercializing life sciences technologies to enable scientific innovations to reach patients. As a consultant to startups, she has enabled two companies to raise their initial rounds of financing. At Affymetrix, she was responsible for strategic marketing for their Academic Research Business Unit, dealing with their largest customer segment. Prior to that, she was Director of an early-stage business unit at Children’s Hospital Boston, where she secured $2.5 M in grant funding and enabled prototype development for six medical device products. She has also managed broad, diverse IP portfolios and closed academic licensing deals worth over $10M. Gini has co-authored numerous papers on NuMedii’s core technology. She received her PhD in Biological Sciences from Purdue University and did post-doctoral work at Harvard Medical School.

Butte, Board of Directors

Atul J. Butte, M.D., Ph.D.


A pediatric endocrinologist by training, Atul is an expert and pioneer in the field of translational bioinformatics. He is an Associate Professor of Pediatrics, and by courtesy, Medicine and Computer Science, at Stanford University and the Lucile Packard Children’s Hospital. He serves on the Board of Directors of the American Medical Informatics Association and on the External Advisory Board of Johnson and Johnson Corporate Office of Science and Technology (COSAT). Dr. Butte is also a scientific founder of Personalis and Carmenta. Atul received his undergraduate degree in Computer Science and medical degree from Brown University, and a Ph.D. in Health Sciences and Technology from Harvard Medical School and MIT.

Sam Saks, Board of Directors

Samuel R. Saks, M.D.


Sam is a board-certified oncologist who was most recently the founding CEO and Chairman of Jazz Pharmaceuticals, Inc. from 2003 until his retirement in 2009. Previously, he was Company Group Chairman of ALZA Corporation and has also held clinical research and development management positions at Schering-Plough, XOMA Corp., and Genentech as well as been a faculty member of UCSF’s Department of Medicine. Sam serves on the Board of Directors at Trubion Pharmaceuticals, Auspex Pharmaceuticals, and Cougar Biotechnology, Inc. He received a B.S. and an M.D. from the University of Illinois.

Ravi Mahatre, Board of Directors

Ravi Mhatre


Ravi is a Partner of Lightspeed and focuses on investments in enterprise IT, mobility, and Internet and cloud-based services and applications. Ravi has 17 years of venture capital experience and before entering venture capital he ran a product management group at Silicon Graphics and also worked in management consulting at Booz Allen and as a software engineer for BDIS, a Silicon Valley biotech instruments manufacturer.

His current investments include Nutanix, Appdynamics, Natera, Mulesoft, Sailpoint, Edgespring, TheFind and Kixeye. He has also served as a board member or board observer for numerous successful venture-backed companies including net.Genesis (NTGX), Verio (VRIO), Riverbed (RVBD), Lifeminders (LFMN), Kosmix (acquired by Walmart), TutorVista (acquired by Pearson), Virsa (acquired by SAP), Waveset (acquired by Oracle), Rapsphere (acquired by Appsense), Masergy (acquired by Abry) and Webspective (acquired by Inktomi), and has been recognized on the Forbes Midas List of top venture capital investors.

Ravi has also served on the Board of Directors of TiE (The Indus Entrepreurs Forum) in Silicon Valley, as a VC advisory board member to DeVenCI, the Deparment of Defense’s start-up technology acquisition forum, and as a judge for the Ernst & Young Entrepreneur of the Year competition.

Ravi holds a BS in Electical Engineering and a BA in Economics from Stanford University and an MBA from Stanford Graduate School of Business.